0001161697-23-000643.txt : 20231229 0001161697-23-000643.hdr.sgml : 20231229 20231229170020 ACCESSION NUMBER: 0001161697-23-000643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231227 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Del Carmen Jeffrey CENTRAL INDEX KEY: 0001816477 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 231528392 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 12-27-2023 X0508 4 2023-12-27 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001816477 Del Carmen Jeffrey 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Commercial Officer 0 Common stock, par value $0.001 per share 2023-12-27 4 M 0 8666 A 22265 D Common stock, par value $0.001 per share 2023-12-27 4 F 0 3839 D 18426 D Restricted Stock Units 2023-12-27 4 M 0 8666 0 D Common Stock 8666 844686 D Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units. Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025. Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023. /s/ Jeffrey Del Carmen 2023-12-29